Bis(2-ethylhexyl) adipate
Common Name: |
Bis(2-ethylhexyl) adipate |
IUPAC Name: |
bis(2-ethylhexyl) hexanedioate |
Molecular Formula: |
C22H42O4 |
SMILES: |
CCCCC(CC)COC(=O)CCCCC(=O)OCC(CC)CCCC |
Inchi: |
1S/C22H42O4/c1-5-9-13-19(7-3)17-25-21(23)15-11-12-16-22(24)26-18-20(8-4)14-10-6-2/h19-20H,5-18H2,1-4H3 |
Inchi Key: |
SAOKZLXYCUGLFA-UHFFFAOYSA-N |
Cas No: |
103-23-1 |
Name |
Value |
Lipinski Violations |
1 |
Ghose Violations |
1 |
Veber Violations |
1 |
Egan Violations |
1 |
Muegge Violations |
2 |
Name |
Value |
Molecular Weight (g/mol) |
370.57 |
Mass (g/mol) |
370.308 |
Molar Refractivity |
110.44 |
Net Charge |
|
HBD |
|
HBA |
4 |
Rt Bonds |
19 |
Rings |
|
TPSA |
52.60 |
Hetero Atoms |
|
Heavy Atoms |
26 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
-67.8 |
Boiling Point (°C@760.00mm Hg) |
416.00 to 418.00 |
Vapor Pressure (mmHg@25.00 °C) |
|
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.91 |
LogP |
|
iLOGP |
5.46 |
XLOGP3 |
6.84 |
WLOGP |
6.07 |
MLOGP |
4.55 |
ESOL Log S |
-5.19 |
ESOL Solubility (mg/ml) |
0.002 |
ESOL Solubility (mol/l) |
0 |
ESOL Class: esol_class |
Moderately soluble |
Ali Log S |
-7.75 |
Ali Solubility (mg/ml) |
0 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Poorly soluble |
Silicos-IT LogSw |
-6.52 |
Silicos-IT Solubility (mg/ml) |
0 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Poorly soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
0 |
PgP Substrate |
1 |
Log Kp (cm/s) |
-3.70 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.785 |
CYP1A2 Inhibitor |
1 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
1 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
1 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
1.917 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
1 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |